About: Management of thrombosis in antiphospholipid antibody syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of thrombosis in antiphospholipid antibody syndrome Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: August 2001)

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2001 (ast) vědecký článek publikovaný v roce 2001 (cs) наукова стаття, опублікована в серпні 2001 (uk) 2001 թվականի օգոստոսին հրատարակված գիտական հոդված (hy) 2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած (hyw) vedecký článok (publikovaný 2001-08) (sk) مقالة علمية (نشرت في أغسطس 2001) (ar) wetenschappelijk artikel (gepubliceerd in 2001-08) (nl) article scientifique publié en 2001 (fr) scientific article (publication date: August 2001) (en) im August 2001 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q28188666-F249C113-7114-497B-826C-E0ED28C1971C
publication date	2001-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28188666-3A0DA0C9-E4F5-4AA2-9779-9832B281E22B
language of work or name	English
cites work	wds:Q28188666-01188828-3ACF-4C11-B2AF-AEAD4F7199C9 wds:Q28188666-0A0AF0E0-5888-4F59-9FFD-26F07C0E3D22 wds:Q28188666-14C9339C-0A18-4E07-93D4-89A8188AEAED wds:Q28188666-23E8D780-795E-40A5-86AE-64D785020596 wds:Q28188666-2C06FA60-8558-44E7-8FF0-901BC9D72E70 wds:Q28188666-3B97CC06-95EB-4FA4-9118-8DEBBE9F7BE1 wds:Q28188666-405578F7-2E80-4A44-AC27-9A99872F5994 wds:Q28188666-4240D9A3-D67E-4BB6-A456-7C46591571CE wds:Q28188666-50976E48-2E90-4A6F-89DC-7A3632A111AE wds:Q28188666-66D60953-FA74-45A8-87B0-94F34C5AA075 wds:Q28188666-689219E4-45C3-4990-ACD7-B4115A4691E6 wds:Q28188666-7E93B37C-972B-4538-BF26-77E632359CCA wds:Q28188666-85591AC0-88CE-42F0-B76C-35DB1101CBFF wds:Q28188666-8775D443-D54F-48FC-A7AE-162B8FE68DB3 wds:Q28188666-8C001E7A-9A1C-482D-80F4-4660D6931B28 wds:Q28188666-8F8CBF95-6EFC-46F4-8952-D9A440B8C25A wds:Q28188666-A2E76568-9046-4C99-8F33-43D557E3C515 wds:Q28188666-A4B9B7CB-D53A-42D4-9CA2-3A0646551CC7 wds:Q28188666-A4E2FDDA-0967-4007-8133-BE709C66604F wds:Q28188666-AA07E27E-5A6E-43AD-A9CD-6D0A3E5776D7 wds:Q28188666-C3BF2CCD-1136-4D54-9B88-4BB9046E09F9 wds:Q28188666-C72B3531-0532-4558-B236-15D1C651572E wds:Q28188666-C7A619DE-62BA-42B5-8C13-E7907B5E5EC0 wds:Q28188666-C92041D2-9D5F-41B5-B01B-EF2E5BD5462E wds:Q28188666-CDBA8809-FCD2-428E-B7B4-EF8C1FAA4532 wds:Q28188666-D3FA5B20-DDE5-45CA-A1CD-06DCB138CAB5 wds:Q28188666-EF4044B5-7B03-465A-B8A1-1B511ACA9B1A wds:Q28188666-FFC295D7-7057-4F7A-8C45-796125B1ED66
cites work	A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis Cerebrovascular ischemic events with high positive anticardiolipin antibodies Monitoring warfarin therapy in patients with lupus anticoagulants Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients The management of thrombosis in the antiphospholipid-antibody syndrome Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen Severe infections in plasmapheresis-treated systemic lupus erythematosus Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases Streptokinase in acute ischemic stroke: an individual patient data meta-analysis : The Thrombolysis in Acute Stroke Pooling Project Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndrome Successful coronary stent implantation in a patient with primary antiphospholipid syndrome Successful thromboendarterectomy for chronic pulmonary embolism in a patient with systemic lupus erythematosus and antiphospholipid syndrome Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism Hydroxychloroquine: past, present, future Antiplatelet factor 4--heparin antibodies in patients with antiphospholipid antibodies Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome. Correction of severe thrombocytopenia with chloroquine in the primary antiphospholipid syndrome.
author name string	wds:Q28188666-BB9D6F1B-2BD7-4D42-B2F4-704E503EBFB7
author name string	M Petri
rdfs:label	Management of thrombosis in antiphospholipid antibody syndrome (en) Management of thrombosis in antiphospholipid antibody syndrome (nl) Management of thrombosis in antiphospholipid antibody syndrome (ast)
skos:prefLabel	Management of thrombosis in antiphospholipid antibody syndrome (en) Management of thrombosis in antiphospholipid antibody syndrome (nl) Management of thrombosis in antiphospholipid antibody syndrome (ast)
name	Management of thrombosis in antiphospholipid antibody syndrome (en) Management of thrombosis in antiphospholipid antibody syndrome (nl) Management of thrombosis in antiphospholipid antibody syndrome (ast)
title	wds:Q28188666-96EDD898-35FB-4D60-932F-92DD183722FA
title	Management of thrombosis in antiphospholipid antibody syndrome (en)
page(s)	wds:Q28188666-C75F8F6B-038B-4AAC-9984-E04B64F2F633
page(s)	633-42, viii
instance of	wds:Q28188666-3B989DA5-0C3A-4D1F-9BE5-30D632424D3B wds:Q28188666-57cc2d06-df24-42e9-92af-edad9e9e7105
instance of	review article scholarly article
main subject	wds:Q28188666-4E188EB4-6F6C-4F0C-BF0E-1794C7E56A86 wds:Q28188666-CE83867C-FF46-42AC-BF6E-4FC860D3C9A5
main subject	antibody thrombosis
PubMed ID	wds:Q28188666-6EBB089A-6C64-4545-B9D1-B36DF883C80E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11534265
PubMed ID	11534265
published in	wds:Q28188666-BB247395-B31B-4414-81B7-42570C97E4D0
published in	Rheumatic Diseases Clinics of North America

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software